Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF OPERATIONS

v3.21.1
STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
Research and development $ 37,237 $ 30,042
Research and development - licenses acquired 10,064 6,273
General and administrative 9,505 9,570
Total operating expenses 56,806 45,885
Loss from operations (56,806) (45,885)
Other income (expense)    
Interest income 708 1,263
Interest expense (3,917) (1,767)
Total other income (expense) (3,209) (504)
Net Loss $ (60,015) $ (46,389)
Net loss per common share outstanding, basic and diluted $ (1.14) $ (1.29)
Weighted average number of common shares outstanding, basic and diluted 52,588,781 36,061,811